Our 7th annual update with ECO:FACT on global ESG regulatory and policy developments affecting the Biopharma sector. Olivier Jaeggi, Managing Director and Chairman, Alba González, Senior ESG Expert, and Marta Barretta, Environmental Law Specialist, focus on topics where ESG policy and regulation are evolving, and what’s coming in the global pipeline of ESG regulations that will impact biopharma companies directly or indirectly.
